BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37125643)

  • 1. Pathway to global elimination of hepatitis B: HBV cure is just the first step.
    Howell J; Seaman C; Wallace J; Xiao Y; Scott N; Davies J; de Santis T; Adda D; El-Sayed M; Feld JJ; Gane E; Lacombe K; Lesi O; Mohamed R; Silva M; Tu T; Revill P; Hellard ME
    Hepatology; 2023 Sep; 78(3):976-990. PubMed ID: 37125643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for the Global Elimination of Hepatitis B.
    Block TM; Chang KM; Guo JT
    Annu Rev Virol; 2021 Sep; 8(1):437-458. PubMed ID: 34586871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure.
    Moini M; Fung S
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What will it take to cure hepatitis B?
    Jeng WJ; Lok ASF
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure.
    Tsounis EP; Tourkochristou E; Mouzaki A; Triantos C
    World J Gastroenterol; 2021 Jun; 27(21):2727-2757. PubMed ID: 34135551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure.
    Yardeni D; Chang KM; Ghany MG
    Gastroenterology; 2023 Jan; 164(1):42-60.e6. PubMed ID: 36243037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B.
    Jeng WJ; Papatheodoridis GV; Lok ASF
    Lancet; 2023 Mar; 401(10381):1039-1052. PubMed ID: 36774930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review.
    Baugh SDP
    Infect Disord Drug Targets; 2017; 17(1):24-35. PubMed ID: 28056752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.
    Wu D; Ning Q
    J Infect Dis; 2017 Nov; 216(suppl_8):S771-S777. PubMed ID: 29156046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
    Wong GLH; Gane E; Lok ASF
    J Hepatol; 2022 Jun; 76(6):1249-1262. PubMed ID: 35589248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments.
    Laupèze B; Vassilev V; Badur S
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1135-1147. PubMed ID: 37847193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel viral and host targets to cure hepatitis B.
    Ko C; Michler T; Protzer U
    Curr Opin Virol; 2017 Jun; 24():38-45. PubMed ID: 28433762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV cure: why, how, when?
    Levrero M; Testoni B; Zoulim F
    Curr Opin Virol; 2016 Jun; 18():135-43. PubMed ID: 27447092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we cure hepatitis B virus with novel direct-acting antivirals?
    Martinez MG; Villeret F; Testoni B; Zoulim F
    Liver Int; 2020 Feb; 40 Suppl 1():27-34. PubMed ID: 32077597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021.
    Khetsuriani N; Lesi O; Desai S; Armstrong PA; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(30):958-963. PubMed ID: 35900928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical cure strategy for hepatitis B: immunomodulatory therapy].
    Xie Q; Ning Q; Wang GQ; Chen CW; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):644-648. PubMed ID: 32911900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
    Nayagam S; Chan P; Zhao K; Sicuri E; Wang X; Jia J; Wei L; Walsh N; Rodewald LE; Zhang G; Ailing W; Zhang L; Chang JH; Hou W; Qiu Y; Sui B; Xiao Y; Zhuang H; Thursz MR; Scano F; Low-Beer D; Schwartländer B; Wang Y; Hallett TB
    Clin Infect Dis; 2021 Mar; 72(5):743-752. PubMed ID: 32255486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.
    Revill PA; Penicaud C; Brechot C; Zoulim F
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30939846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies.
    Degasperi E; Anolli MP; Lampertico P
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.